NCT06704256 SCM Muscle as a Marker for Frailty in Patients Undergoing ENT Surgery
| NCT ID | NCT06704256 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Icahn School of Medicine at Mount Sinai |
| Condition | Frailty |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2024-10-28 |
| Primary Completion | 2026-10-23 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2024-10-28 with a primary completion date of 2026-10-23.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study focuses on evaluating the relationship between physical frailty and measurements of the muscles of the neck in patients undergoing non-cancer Head and Neck surgery.
Eligibility Criteria
Inclusion Criteria: • Non-oncologic patients presenting for head and neck surgery with available neck CT scans. Exclusion Criteria: * Patients undergoing cancer surgery * Patients under18 years of age * Patients without pre-surgical CT-scans of the head and neck
Contact & Investigator
Gabriela Hernandez
PRINCIPAL INVESTIGATOR
Icahn School of Medicine at Mount Sinai
Frequently Asked Questions
Who can join the NCT06704256 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Frailty. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06704256 currently recruiting?
Yes, NCT06704256 is actively recruiting participants. Contact the research team at Gabriela.hernandezmeza@mountsinai.org for enrollment information.
Where is the NCT06704256 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT06704256 clinical trial?
NCT06704256 is sponsored by Icahn School of Medicine at Mount Sinai. The principal investigator is Gabriela Hernandez at Icahn School of Medicine at Mount Sinai. The trial plans to enroll 100 participants.